This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 May;12(5):800-6.
doi: 10.3201/eid1205.050866.

Aedes aegypti larval indices and risk for dengue epidemics

Affiliations

Aedes aegypti larval indices and risk for dengue epidemics

Lizet Sanchez et al. Emerg Infect Dis. 2006 May.

Abstract

We assessed in a case-control study the test-validity of Aedes larval indices for the 2000 Havana outbreak. "Cases" were blocks where a dengue fever patient lived during the outbreak. "Controls" were randomly sampled blocks. Before, during, and after the epidemic, we calculated Breteau index (BI) and house index at the area, neighborhood, and block level. We constructed receiver operating characteristic (ROC) curves to determine their performance as predictors of dengue transmission. We observed a pronounced effect of the level of measurement. The BI(max) (maximum block BI in a radius of 100 m) at 2-month intervals had an area under the ROC curve of 71%. At a cutoff of 4.0, it significantly (odds ratio 6.00, p<0.05) predicted transmission with 78% sensitivity and 63% specificity. Analysis of BI at the local level, with human-defined boundaries, could be introduced in control programs to identify neighborhoods at high risk for dengue transmission.

PubMed Disclaimer

Figures

Figure
Figure
Spatial distribution of dengue cases and Breteau indices (BI) at the block level before, during, and after the dengue outbreak, Playa Municipality, Havana, 2000.

References

    1. Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis. 2002;2:33–42. 10.1016/S1473-3099(01)00171-2 - DOI - PubMed
    1. Deen JL. The challenge of dengue vaccine development and introduction. Trop Med Int Health. 2004;9:1–3. 10.1046/j.1365-3156.2003.01159.x - DOI - PubMed
    1. Guzman MG, Mune M, Kouri G. Dengue vaccine: priorities and progress. Expert Rev Anti Infect Ther. 2004;2:895–911. 10.1586/14789072.2.6.895 - DOI - PubMed
    1. Gubler DJ, Clark GG. Community involvement in the control of Aedes aegypti. Acta Trop. 1996;61:169–79. 10.1016/0001-706X(95)00103-L - DOI - PubMed
    1. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003;27:1–13. 10.1016/S1386-6532(03)00010-6 - DOI - PubMed

Publication types

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /